Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.59 +0.21 (+6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) EBT Margin (2020 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) recorded EBT Margin of -4770.71% in Q2 2026, down 2870.71 percentage points from -1900.00% a year earlier but up 9019.91 percentage points from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) EBT Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Insight Molecular Diagnostics' EBT Margin came in at -3011.86% as of Jun 30, 2026, down 1513.55 percentage points year-over-year; for FY2025, it was -1260.76%, up 1984.37 percentage points from FY2024.

  • Annual EBT Margin has a five-year change of +1303.87 percentage points (FY2020 to FY2025).
  • Across earlier years, EBT Margin came in at -3245.14% in FY2024 (-1591.44 pp), -1653.69% in FY2023 (+289.10 pp), -1942.80% in FY2022 (+462.62 pp) and -2405.41% in FY2021 (+159.22 pp).
  • Quarterly EBT Margin has ranged from -13790.63% in Q1 2026 to 2006.40% in Q1 2023 over the past five years.
  • On a year-over-year basis, EBT Margin rose in five of the last eight quarters, with an average year-over-year change of -1077.71 percentage points.
  • Peak year-over-year performance for EBT Margin in the last five years was a gain of 7502.94 percentage points in Q3 2025, against a drop of 13472.62 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -13790.63% (Q1 2026), -2057.51% (Q4 2025) and -4249.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 16.04%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 12.10%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 17.21%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 36.46%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 18.13%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 23.74%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 19.48%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 29.86%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 11.12%
10 Insight Molecular Diagnostics 110.27 Mn 33.98 Mn 157,000.00 -4,770.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,770.71%
Mar 31, 2026 -13,790.63%
Dec 31, 2025 -2,057.51%
Sep 30, 2025 -4,249.23%
Jun 30, 2025 -1,900.00%
Mar 31, 2025 -318.01%
Dec 31, 2024 -2,262.92%
Sep 30, 2024 -11,752.17%
Jun 30, 2024 -4,453.85%
Mar 31, 2024 -5,186.93%
Dec 31, 2023 -5,092.99%
Sep 30, 2023 -1,512.59%
Jun 30, 2023 -1,799.78%
Mar 31, 2023 2,006.40%
Dec 31, 2022 -4,385.77%
Sep 30, 2022 -2,713.43%
Jun 30, 2022 -575.53%
Mar 31, 2022 -898.16%
Dec 31, 2021 -997.16%
Sep 30, 2021 -1,402.44%
API Access

Insight Molecular Diagnostics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY